compendium.ch

Jinarc® 13.09.2016

Nouvelle commercialisation Otsuka Pharmaceutical (Switzerland) GmbH

Nouvelle commercialisation
Comprimés à 15 mg, 30 mg, 45 mg, 60 mg et 90 mg de tolvaptan.

Produit
Description

Firme

Emballage le plus petit

Prix
CHF

Cat. de remise
Cat. de remboursement

JINARC cpr 15 mg

C03XA01 Tolvaptan

Otsuka Pharmaceutical (Switzerland) GmbH blister 28 pce

A
LS: quote-part normale: 10% (LIM)

JINARC cpr 30 mg

C03XA01 Tolvaptan

Otsuka Pharmaceutical (Switzerland) GmbH blister 28 pce

A
LS: quote-part normale: 10% (LIM)

JINARC cpr 45 mg/15 mg

C03XA01 Tolvaptan

Otsuka Pharmaceutical (Switzerland) GmbH blister 56 pce

A
LS: quote-part normale: 10% (LIM)

JINARC cpr 60 mg/30 mg

C03XA01 Tolvaptan

Otsuka Pharmaceutical (Switzerland) GmbH blister 56 pce

A
LS: quote-part normale: 10% (LIM)

JINARC cpr 90 mg/30 mg

C03XA01 Tolvaptan

Otsuka Pharmaceutical (Switzerland) GmbH blister 56 pce

A
LS: quote-part normale: 10% (LIM)